Atlas Trials

Primary Mediastinal Lymphoma

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Primary Mediastinal Lymphoma

RecordFirmDate
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021 (NCT05518383)Federal Research Institute of Pediatric Hematology, Oncology and Immunology2022-05-25
Multicenter Study of Safety and Efficacy Nivolumab at the Fixed Dose 40 mg (Nivo40) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed PMBL (NCT06188676)National Research Center for Hematology, Russia2022-04-01
CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML (NCT04787263)Bambino Gesù Hospital and Research Institute2021-03-04
Open-Label, Multi-Center, Two-Part, Ph1 Study to Characterize the PKs of an Intravenous Micro-Dose of [14C]-Tazemetostat (EPZ 6438) and the ADME of an Oral [14C]-Labeled Dose of Tazemetostat in Subjects With B-Cell Lymphomas or Adv Solid Tumors (NCT03010982)Epizyme, Inc.2018-06-20
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL (NCT03019666)Masonic Cancer Center, University of Minnesota2017-10-18
Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients (NCT03028103)Epizyme, Inc.2017-03-27

Track Primary Mediastinal Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.